RESUMO
Infection with SARS-CoV-2 leading to COVID-19 induces hyperinflammatory and hypercoagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been well reported in COVID-19 patients. While most DVTs occur in a lower extremity, involvement of the upper extremity is uncommon. In this report, we describe the first reported patient with an upper extremity DVT recurrence secondary to COVID-19 infection.
Assuntos
COVID-19/complicações , COVID-19/diagnóstico , Trombose Venosa/complicações , Trombose Venosa/diagnóstico , Idoso de 80 Anos ou mais , Transtornos da Coagulação Sanguínea/complicações , Humanos , Masculino , Recidiva Local de Neoplasia , Reação em Cadeia da Polimerase , RNA Viral , Recidiva , Fatores de Risco , Extremidade Superior/irrigação sanguínea , Trombose Venosa/terapiaAssuntos
COVID-19/psicologia , Comunicação , Motivação , Apoio Social , Estudantes de Medicina/psicologia , Telefone , Idoso , Empatia , Humanos , Isolamento SocialRESUMO
Coronavirus 2019 (COVID-19) has been reported to trigger Guillain-Barré syndrome (GBS). While uncommon, recurrent GBS (rGBS) episodes, triggered by antecedent viral infections, have been reported in a small proportion of GBS patients, here we describe a patient with a recurrent case of GBS, occurring secondary to COVID-19 infection. Before this patient's episode, he had two prior GBS flares, each precipitated by a viral infection followed by complete recovery besides intermittent paresthesias. We also consider the nosology of this illness in the spectrum of rGBS and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), with their differing natural histories, prognosis, and therapeutic approaches. For patients who have a history of inflammatory demyelinating polyradiculopathies who develop COVID-19, we recommend close observation for neurologic symptoms over the next days and weeks.
